Rating
Hold
Price target
$198
Previous
$198
Implied upside
+34%

Cantor Fitzgerald analyst Thomas Blakey reiterated a Neutral rating and $198.00 price target on Palantir (NASDAQ: PLTR).

“Palantir posted a 5% beat, including a 6% beat to US Commercial revenue in 4Q25 (vs. 15% beat to US Commercial last quarter). Margins continue to expand, impressively reaching Rule of 127% in 4Q.

The company guided a very strong US Commercial to accelerate from 109% growth in C25 (which accelerated from 53% in C24) to “in excess of” 115% in C26, which was 29% higher than Street/Consensus forecasting for US Commercial at the low end of this new guide.

Strength in the quarter was driven by expanded spending (NDR 139% vs.

134% last qtr., 120% 4Q24), partially driven by AIP, inline with our checks, with existing customers as TTM growth at top 20 customers accelerated to 45% growth from 38% last quarter and a six point more difficult compare with outlook supported by RPO growth of 143% vs.

66% (20pt easier compare) and 95% growth in cRPO, nearly double from 56% last quarter on a similar compare.

Our estimates move meaningfully higher, driven by US Commercial strong guide and US Govt revenue, where US Federal shutdowns appeared to not impact mission-critical spending in the US, which expanded in 4Q25, driving our C26 forecasts higher for this segment, as well.

We continue to view Palantir as a leader in AI-driven analytics that meaningfully transform complex enterprise and government data sets into operational insights, yet we reit our Neutral rating as we lower our target multiples to align with overall software multiple compression in recent months maintaining our $198 PT, or 51x C27E revenue (versus PLTR’s historical 3-year NTM average multiple of 38x and median of 22x).”

Disclaimer
The price target and rating on this page are the opinion of the issuing research firm and its analyst, not of Price Target. This page is published for informational purposes only and is not investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consider your own circumstances and consult a licensed financial adviser before making investment decisions.

This research note is reproduced verbatim from the issuing firm. Price Target never edits, paraphrases or alters analysts’ words — we only republish them in one place.

Share

Share on
Price Target is an archive of Wall Street analyst research, published for informational purposes only. Nothing on this site is investment advice, a recommendation, or an offer to buy or sell any security. Analyst ratings and price targets are the opinions of the issuing firms, not of Price Target. Always do your own research or consult a licensed financial adviser.